Thrombosis, Bleeding, and the Promise of Factor XI(a) Inhibition

J Am Coll Cardiol. 2024 Feb 13;83(6):679-681. doi: 10.1016/j.jacc.2023.12.003.

¹ Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Catholic University Medical School, Rome, Italy. Electronic address: felicita.andreotti@unicatt.it.
² Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Catholic University Medical School, Rome, Italy.
³ Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.

No abstract available

Keywords: asundexian; atrial fibrillation; bleeding; factor XI inhibitor; myocardial infarction; placebo; stroke.

Publication types